Related Experiment Video
Updated: Apr 27, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
JNK3 is required for the cytoprotective effect of exendin 4
Hélène Ezanno1, Valérie Pawlowski2, Saida Abdelli3
1Lille 2 University, University of Lille Nord de France, European Genomic Institute for Diabetes, EGID FR 3508, UMR 8199, Lille, France.
Abstract:
Preservation of beta cell against apoptosis is one of the therapeutic benefits of the glucagon-like peptide-1 (GLP1) antidiabetic mimetics for preserving the functional beta cell mass exposed to diabetogenic condition including proinflammatory cytokines. The mitogen activated protein kinase 10 also called c-jun amino-terminal kinase 3 (JNK3) plays a protective role in insulin-secreting cells against death caused by cytokines. In this study, we investigated whether the JNK3 expression is associated with the protective effect elicited by the GLP1 mimetic exendin 4. We found an increase in the abundance of JNK3 in isolated human islets and INS-1E cells cultured with exendin 4. Induction of JNK3 by exendin 4 was associated with an increased survival of INS-1E cells. Silencing of JNK3 prevented the cytoprotective effect of exendin 4 against apoptosis elicited by culture condition and cytokines. These results emphasize the requirement of JNK3 in the antiapoptotic effects of exendin 4.
Insights
Glucagon-like peptide-1 (GLP1) mimetics protect beta cells from death. This study shows that the protein JNK3 is essential for GLP1 mimetic exendin-4 to prevent beta cell apoptosis, highlighting JNK3
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- Glucagon-like peptide-1 (GLP1) mimetics offer therapeutic benefits by preserving beta cell mass in diabetes.
- Proinflammatory cytokines contribute to beta cell dysfunction and apoptosis in diabetogenic conditions.
- Mitogen-activated protein kinase 10 (JNK3) is known to protect insulin-secreting cells from cytokine-induced death.
Purpose of the Study:
- To investigate the association between JNK3 expression and the protective effects of the GLP1 mimetic exendin-4.
- To determine if JNK3 mediates the antiapoptotic actions of exendin-4 in beta cells.
Main Methods:
- Isolated human islets and INS-1E cells were cultured with exendin-4.
- JNK3 abundance was measured in response to exendin-4 treatment.
- JNK3 was silenced to assess its role in exendin-4's cytoprotective effects against apoptosis induced by culture conditions and cytokines.
Main Results:
- Exendin-4 treatment increased the abundance of JNK3 in both human islets and INS-1E cells.
- Increased JNK3 expression correlated with enhanced survival of INS-1E cells.
- Silencing JNK3 abolished the protective effect of exendin-4 against cytokine-induced and culture-induced apoptosis.
Conclusions:
- JNK3 expression is upregulated by the GLP1 mimetic exendin-4.
- JNK3 is a critical mediator of exendin-4's antiapoptotic effects in beta cells.
- Targeting JNK3 may represent a therapeutic strategy for preserving beta cell function in diabetes.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
07:55Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
Published on: September 25, 2017
Related Concept Videos
The JAK-STAT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The Extrinsic Apoptotic Pathway
NF-kB-dependent Signaling Pathway
MAPK Signaling Cascades
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...